Page last updated: 2024-08-25

3-amino-1,2,4-triazine and Carcinoma, Pancreatic Ductal

3-amino-1,2,4-triazine has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bassani, D; Carbone, D; Cascioferro, S; Cirrincione, G; Dall'Acqua, S; De Franco, M; Diana, P; Gandin, V; Moro, S; Parrino, B; Pavan, M; Pecoraro, C; Sut, S	1

Other Studies

1 other study(ies) available for 3-amino-1,2,4-triazine and Carcinoma, Pancreatic Ductal

Article	Year
Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma. Marine drugs, 2023, May-04, Volume: 21, Issue:5 Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Humans; Molecular Docking Simulation; Pancreatic Neoplasms; Proto-Oncogene Proteins p21(ras); Triazines	2023

Article

Year

Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma.

Marine drugs, 2023, May-04, Volume: 21, Issue:5

Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Humans; Molecular Docking Simulation; Pancreatic Neoplasms; Proto-Oncogene Proteins p21(ras); Triazines

2023